Pharmaceutical Water Market to Register a Steady CAGR of 9.40% Between 2023 – 2031 – Growth Plus Reports

·6 min read
Growth Plus Reports
Growth Plus Reports

Newark, New Castle, USA, March 24, 2023 (GLOBE NEWSWIRE) -- The global pharmaceutical water market, estimated at US$ 28.90 billion in 2023, is projected to surpass US$ 65 billion by 2031, at a revenue CAGR of 9.40%, according to the latest evaluation by Growth Plus Reports. The study examines the best impactful strategies, macroeconomic conditions, trends and prospects, competitive environments, changing market dynamics, market size, data and projections, and key investment areas.

Request a Free Sample Copy of the Research Report:

Pharmaceutical Water Market Scope

Report Attribute


Market size value in 2022

US$ 28.9 billion

Revenue forecast in 2031

US$ 65 billion

Growth Rate

CAGR of 9.4% from 2023 to 2031

Base year for estimation


Forecast Period


Historical Year


Segments covered

Type, End-user, and Region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Key Takeaways:

  • The growth of the biopharmaceutical and generic injectable industries will drive the demand for pharmaceutical water during the forecast period.

  • The significant rise in the prevalence of infectious diseases will encourage market revenue growth.

  • North America will dominate the global market.

Request Free Sample Copy of the Research Report:

Market Drivers
An increase in the development of life-saving treatments and the rising need for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides are the primary factors driving the revenue growth of the global pharmaceutical water market. Additionally, the growth of the biopharmaceutical and generic injectable industries and the significant rise in the prevalence of infectious diseases contribute to market revenue growth. Furthermore, technological advancements and advances in microbiology support the market's revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global pharmaceutical water market from three perspectives: Type, End-user, and Region.

Type Segmentation: Based on the type, the global pharmaceutical water market is segmented into HPLC grade water, water for injection, water for inhalation, water for irrigation, non-potable water, and portable water. The HPLC-grade water segment dominates the market with the largest revenue share because laboratories only use trusted and well-established HPLC technology to separate, recognize, and quantify components in a mixture.

End-User Segmentation: Based on the end-user, the global pharmaceutical water market is segmented into pharmaceutical & biotechnology companies, academic & research laboratories, and others. The pharmaceutical & biotechnology companies segment dominates the market because pharmaceutical water is the most needed commodity in the pharmaceutical industry.

Regional Growth Dynamics
Based on the region, the global pharmaceutical water market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global pharmaceutical water market with the largest revenue share. The considerable revenue share of North America in the global pharmaceutical water market can be attributed to this region having numerous significant pharmaceutical companies, a well-developed healthcare infrastructure, and a strong demand for advanced healthcare services.

Request for Customization –

Competitive Landscape

The following are the top companies in the global pharmaceutical water market:

  • Merck KGaA

  • B. Braun Melsungen AG

  • Baxter International Inc.

  • Thermo Fisher Scientific Inc.

  • Cytiva (Danaher)

  • Intermountain Life Sciences

  • Standard Reagents, Pvt. Ltd.

  • CovaChem LLC.

  • FUJIFILM Irvine Scientific

  • Fresenius Kabi AG

  • Pfizer Inc.

The market for pharmaceutical water is very competitive and complex. Prominent companies are developing new products and forming strategic alliances to fulfill the growing global demand and maintain a strong market position.

Table of Content


    1. Market Ecosystem

    2. Timeline Under Consideration

      1. Historical Years – 2021

      2. Base Year – 2022

      3. Forecast Years – 2023 to 2031

    3. Currency Used in the Report


    1. Research Approach

    2. Data Collection Methodology

    3. Data Sources

      1. Secondary Sources

      2. Primary Sources

    4. Market Estimation Approach

      1. Bottom Up

      2. Top Down

    5. Market Forecasting Model

    6. Limitations and Assumptions


    1. Current Market Trends (COVID-19 Perspective)

    2. Key Players & Competitive Positioning (2022)

    3. Regulatory Landscape

    4. Reimbursement Scenario


    1. Drivers

    2. Restraints/Challenges

    3. Opportunities


    1. HPLC Grade Water

    2. Water for Injection

      1. Sterile

      2. Bacteriostatic

    3. Water for Inhalation

    4. Water for Irrigation

    5. Non-potable Water

    6. Portable Water


    1. Pharmaceutical & Biotechnology Companies

    2. Academic & Research Laboratories

    3. Others

TOC Continued…

Buy this Premium Research Report:


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

  • Comprehensive quantitative and qualitative insights at segment and sub-segment level

  • Covid 19 impact trends and perspective

  • Granular insights at global/regional/country level

  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

  • Blanket coverage on competitive landscape

  • Winning imperatives

  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market


  • Distributor Landscape Assessment

  • Pricing Intelligence

  • Customer Base Assessment

  • Investment & Initiatives Analysis

  • 'Business Profile' of Key Players

Schedule a call with our analyst:

Visit our report store at -

Browse related reports:

3D Bioprinting Market by Components (3D Bioprinters and Bio-inks), by Materials (Hydrogel, Cell, Extracellular Matrices, and Biomaterials), by Application (Pharmaceuticals, Organ & Tissue Regeneration,3D Cell Culture, and Others), and by End-user (Research Centers & Academics, Biopharmaceutical, and Others) – Global Outlook & Forecast 2022-2030

IV Flush Syringe Market by Type (Saline IV Flush Syringe and Heparin IV Flush Syringe), by Application (Cardiac Diseases, Rheumatoid Arthritis, Diabetes, Cancer, and Others), by End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others) - Global Outlook & Forecast 2022-2030

Pharmaceutical Lipids Market by Product (Triglycerides, Phospholipids, Sphingolipids, Cholesterol, Fatty Acids), Source (Synthetic, Semi-synthetic, And Natural), Form (Liquid, Semi-solid, Solid), Application (Conventional Lipid-Based Drug Delivery Systems, Self-Emulsifying Drug Delivery Systems, Self-Microemulsifying Drug Delivery Systems, Liposomes, Solid Lipid Nanoparticles & Nanostructured Lipid Carriers), and End-user (Biopharmaceutical Companies, Contract Research Organizations, Academics & Research Institutes) – Global Outlook & Forecast 2022-2030

Contract Development and Manufacturing Organization (CDMO) Market By Service (Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO)) - Global Outlook & Forecast 2022-2030

Heparin Market By Product Type (Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH)), By Source (Porcine and Bovine), By Application (Heart Attacks, Stroke, Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, and Others), By End User (Hospitals & ASCs, Clinics, and Others) - Global Outlook & Forecast 2022-2030

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web: